Article
C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.
Molecular cancer therapeutics - 1 Jun 2002
Imai Yasuo, Nakane Minoru, Kage Kumie, Tsukahara Satomi, Ishikawa Etsuko, Tsuruo Takashi, Miki Yoshio, Sugimoto Yoshikazu
Abstract excerpt
Breast cancer resistance protein (BCRP) confers multidrug resistance to cancer cells against agents such as SN-38 (an active metabolite of irinotecan), mitoxantrone, and topotecan. Among 59 human tumor cell lines tested, 6 cell lines, A549, NCI-H460, KM-12, HT-29, OVCAR-5, and RPMI8226, showed high BCRP expression. BCRP cDNA was isolated from 11 cancer cell lines and three variant cDNAs [G34A substituting Met for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
